Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Cyclically Adjusted Revenue per Share: ₺122.55 (As of Mar. 2026)


IST:SELEC Selcuk Ecza Deposu Ticaret ve Sanayi AS IST:SELEC
79 GF Score
Price ₺202.00
GF Value ₺88.03
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Selcuk Ecza Deposu Ticaret venayi AS Cyclically Adjusted Revenue per Share?

Selcuk Ecza Deposu Ticaret venayi AS IST:SELEC +0.75% 79 Cyclically Adjusted Revenue per Share is ₺122.55 as of Mar. 2026. GuruFocus rates IST:SELEC with a GF Score™ of 79/100 and a GF Value™ of ₺88.03 (Significantly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Selcuk Ecza Deposu Ticaret venayi AS's adjusted revenue per share for the three months ended in Mar. 2026 was ₺83.616. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₺122.55 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Selcuk Ecza Deposu Ticaret venayi AS's average Cyclically Adjusted Revenue Growth Rate was 33.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 46.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 48.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Selcuk Ecza Deposu Ticaret venayi AS was 56.90% per year. The lowest was 20.80% per year. And the median was 46.50% per year.

As of today (2026-07-11), Selcuk Ecza Deposu Ticaret venayi AS's current stock price is ₺202.00. Selcuk Ecza Deposu Ticaret venayi AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₺122.55. Selcuk Ecza Deposu Ticaret venayi AS's Cyclically Adjusted PS Ratio of today is 1.65.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Selcuk Ecza Deposu Ticaret venayi AS was 1.82. The lowest was 0.23. And the median was 0.67.


Selcuk Ecza Deposu Ticaret venayi AS  (IST:SELEC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Selcuk Ecza Deposu Ticaret venayi AS's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=202.00/122.55
=1.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Selcuk Ecza Deposu Ticaret venayi AS was 1.82. The lowest was 0.23. And the median was 0.67.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Selcuk Ecza Deposu Ticaret venayi AS Cyclically Adjusted Revenue per Share Related Terms


Selcuk Ecza Deposu Ticaret venayi AS Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Selcuk Ecza Deposu Ticaret venayi AS's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Selcuk Ecza Deposu Ticaret venayi AS Cyclically Adjusted Revenue per Share Chart

Selcuk Ecza Deposu Ticaret venayi AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.64 35.79 57.32 83.54 112.53

Selcuk Ecza Deposu Ticaret venayi AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.15 98.36 105.45 112.53 122.55

IST:SELEC vs MCK, CAH, COR: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Selcuk Ecza Deposu Ticaret venayi AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Selcuk Ecza Deposu Ticaret venayi AS Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Selcuk Ecza Deposu Ticaret venayi AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Selcuk Ecza Deposu Ticaret venayi AS's Cyclically Adjusted PS Ratio falls into.


IST:SELEC
79GF Score
Selcuk Ecza Deposu Ticaret ve Sanayi AS IST:SELEC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Selcuk Ecza Deposu Ticaret venayi AS Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Selcuk Ecza Deposu Ticaret venayi AS's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=83.616/330.2130*330.2130
=83.616

Current CPI (Mar. 2026) = 330.2130.

Selcuk Ecza Deposu Ticaret venayi AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.458 241.018 4.738
201609 3.290 241.428 4.500
201612 3.704 241.432 5.066
201703 4.308 243.801 5.835
201706 4.130 244.955 5.567
201709 4.208 246.819 5.630
201712 4.563 246.524 6.112
201803 5.288 249.554 6.997
201806 5.253 251.989 6.884
201809 5.389 252.439 7.049
201812 5.756 251.233 7.566
201903 6.704 254.202 8.709
201906 6.916 256.143 8.916
201909 7.165 256.759 9.215
201912 7.892 256.974 10.141
202003 8.883 258.115 11.364
202006 7.591 257.797 9.723
202009 8.372 260.280 10.621
202012 9.015 260.474 11.429
202103 9.323 264.877 11.623
202106 9.371 271.696 11.389
202109 10.615 274.310 12.778
202112 12.905 278.802 15.285
202203 13.797 287.504 15.847
202206 16.225 296.311 18.081
202209 18.622 296.808 20.718
202212 88.549 296.797 98.519
202303 51.044 301.836 55.843
202306 49.856 305.109 53.958
202309 49.249 307.789 52.837
202312 63.369 306.746 68.217
202403 61.939 312.332 65.485
202406 54.352 314.175 57.127
202409 63.676 315.301 66.688
202412 78.407 315.605 82.036
202503 79.003 319.799 81.576
202506 58.142 322.561 59.521
202509 67.963 324.800 69.096
202512 77.724 324.054 79.201
202603 83.616 330.213 83.616

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₺122.55 mean?
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) has a Cyclically Adjusted Revenue per Share of ₺122.55 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors.
Is Selcuk Ecza Deposu Ticaret venayi AS's Cyclically Adjusted Revenue per Share too high?
Selcuk Ecza Deposu Ticaret venayi AS's current Cyclically Adjusted Revenue per Share is ₺122.55. Overall, Selcuk Ecza Deposu Ticaret venayi AS has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selcuk Ecza Deposu Ticaret venayi AS's Cyclically Adjusted Revenue per Share compare to MCK and CAH?
Selcuk Ecza Deposu Ticaret venayi AS's Cyclically Adjusted Revenue per Share of ₺122.55 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. Selcuk Ecza Deposu Ticaret venayi AS's current Cyclically Adjusted Revenue per Share is ₺122.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selcuk Ecza Deposu Ticaret venayi AS stock overvalued right now?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺88.03, compared to a current price of ₺202.00 — trading 129.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₺122.55. Selcuk Ecza Deposu Ticaret venayi AS's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC), the current Cyclically Adjusted Revenue per Share is ₺122.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Overvalued in 2026?

Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS stock appears to be overvalued. The current stock price of ₺202.00 is trading 129.5% above its estimated GF Value™ of ₺88.03. GuruFocus considers Selcuk Ecza Deposu Ticaret venayi AS to be Significantly Overvalued.

Key valuation signals for IST:SELEC:

  • Cyclically Adjusted Revenue per Share: ₺122.55
  • GF Value™: ₺88.03 vs. price of ₺202.00 (129.5% above fair value)
  • GF Score™: 79/100 with 8 warning signs

No single metric tells the full story. See the IST:SELEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Selcuk Ecza Deposu Ticaret venayi AS Business Description

Address Altunizade Mah. Kusbakisi Cad. No: 37, Nakkastepe, Istanbul, TUR, 34662
Selcuk Ecza Deposu Ticaret ve Sanayi AS and its subsidiaries are in the business of export and import of drugs and patent medicines, medical supplies with pharmacy depot operations and also organize distribution channels between drug manufacturers, hospitals, and pharmacies. The company also distributes cosmetics, personal care, infant food, vitamins, medical and similar products.
79GF Score

Get the complete analysis for IST:SELEC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺202.00
Price
₺88.03
GF Value